Home » Stocks » MYO

Myomo Inc. (MYO)

Stock Price: $7.77 USD -0.27 (-3.36%)
Updated Jul 29, 2021 4:00 PM EDT - Market closed
After-hours: $8.00 +0.23 (2.96%) Jul 29, 5:50 PM
Market Cap 45.06M
Revenue (ttm) 8.91M
Net Income (ttm) -10.72M
Shares Out 5.19M
EPS (ttm) -2.56
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 29
Last Price $7.77
Previous Close $8.04
Change ($) -0.27
Change (%) -3.36%
Day's Open 8.11
Day's Range 7.60 - 8.24
Day's Volume 198,233
52-Week Range 3.46 - 18.88

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disord...

2 days ago - Business Wire

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disord...

6 days ago - Business Wire

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disord...

1 month ago - Business Wire

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disord...

1 month ago - Business Wire

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disord...

1 month ago - Business Wire

Myomo, Inc. (MYO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

1 month ago - Zacks Investment Research

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disord...

1 month ago - Business Wire

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disord...

2 months ago - Business Wire

Myomo, Inc. (MYO) delivered earnings and revenue surprises of 17.39% and 31.24%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disord...

2 months ago - Business Wire

Myomo, Inc. (MYO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 months ago - Zacks Investment Research

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disord...

3 months ago - Business Wire

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disord...

3 months ago - Business Wire

Myomo, Inc. (MYO) delivered earnings and revenue surprises of 21.28% and 14.50%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disord...

4 months ago - Business Wire

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disord...

4 months ago - Business Wire

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disord...

4 months ago - Business Wire

Myomo, Inc. (MYO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

4 months ago - Zacks Investment Research

BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disord...

5 months ago - Business Wire

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurologi...

5 months ago - Business Wire

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurologi...

6 months ago - Business Wire

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurologi...

6 months ago - Business Wire

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurologi...

6 months ago - Business Wire

Three currently-undervalued MedTech stocks are flourishing on the back of a few uptrends.

Other stocks mentioned: TMDX, XGN
7 months ago - Zacks Investment Research

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurologi...

8 months ago - Business Wire

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company offering increased functionality for individuals suffering from neurol...

8 months ago - Business Wire

Myomo, Inc.'s (MYO) CEO Paul Gudonis on Q3 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurologi...

8 months ago - Business Wire

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurologi...

8 months ago - Business Wire

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American:MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurologic...

8 months ago - Business Wire

Myomo (MYO) is in the news Wednesday following an announcement about Medicare authorization that sent MYO stock soaring higher. The post Myomo News: MYO Stock Surges 32% on Medicare Authorization appear...

10 months ago - InvestorPlace

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Myomo, Inc.

10 months ago - Business Wire

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Myomo, Inc.

10 months ago - Business Wire

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Myomo, Inc.

11 months ago - Business Wire

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Myomo, Inc.

11 months ago - Business Wire

Myomo, Inc.'s (MYO) CEO Paul Gudonis on Q2 2020 Results - Earnings Call Transcript

11 months ago - Seeking Alpha

Myomo, Inc. (MYO) delivered earnings and revenue surprises of 14.50% and 43.17%, respectively, for the quarter ended June 2020.

11 months ago - Zacks Investment Research

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Myomo, Inc.

11 months ago - Business Wire

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Myomo, Inc.

11 months ago - Business Wire

Myomo, Inc. (MYO) CEO Paul Gudonis on Q1 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Myomo, Inc. (MYO) delivered earnings and revenue surprises of -29.38% and 29.23%, respectively, for the quarter ended March 2020.

1 year ago - Zacks Investment Research

Myomo's (MYO) CEO Paul Gudonis on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Myomo, Inc. (MYO) delivered earnings and revenue surprises of -7.37% and 8.64%, respectively, for the quarter ended December 2019.

1 year ago - Zacks Investment Research

Myomo, Inc. (MYO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

1 year ago - Zacks Investment Research

Myomo Inc (NYSE: MYO) shares ran wild Tuesday and the momentum continued in Wednesday's session.

1 year ago - Benzinga

Myomo, Inc. (MYO) CEO Paul Gudonis on Q3 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Myomo, Inc. (MYO) delivered earnings and revenue surprises of 0.00% and -53.31%, respectively, for the quarter ended September 2019.

1 year ago - Zacks Investment Research

Myomo, Inc. (MYO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

1 year ago - Zacks Investment Research

Myomo's (MYO) CEO Paul Gudonis on Q2 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Myomo, Inc. (MYO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

1 year ago - Zacks Investment Research

About MYO

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to restore function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord inj... [Read more...]

Industry
Medical Devices
IPO Date
Jun 12, 2017
CEO
Paul Gudonis
Employees
62
Stock Exchange
NYSEAMERICAN
Ticker Symbol
MYO
Full Company Profile

Financial Performance

In 2020, Myomo's revenue was $7.58 million, an increase of 97.60% compared to the previous year's $3.84 million. Losses were -$11.56 million, 7.94% more than in 2019.

Financial Statements

Analyst Forecasts

According to 2 analysts, the average rating for Myomo stock is "Buy." The 12-month stock price forecast is 21.90, which is an increase of 181.85% from the latest price.

Price Target
$21.90
(181.85% upside)
Analyst Consensus: Buy